1. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutate rate;Goldie;Cancer Treat. Rep.,1979
2. Rationale for the use of alternating non cross-resistant chemotherapy;Goldie;Cancer Treat. Rep.,1982
3. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine and imidazole carboxamide versus MOPP;Bonadonna;Cancer,1975
4. Alternating drug combinations in the treatment of advanced Hodgkin's disease;Santoro;N. Eng. J. Med.,1982
5. No response or survival improvement in small cell lung cancer after sequential chemotherapy with three non-cross resistant drug regiments;Pavlidis,1991